USD/CNH
7.29730/87
03-March-25 14:19:51
realtime
Forex
+0.00267
+0.04%
Today's range
7.28327 - 7.30581
ISIN
FXUSDCNH
Source
FX
-
TFI International (NYSE:TFII) Hits New 1-Year Low After Analyst Downgrade
03 Mar 2025 13:16:14 By Buzz FX
-
E2open Parent (NYSE:ETWO) Reaches New 52-Week Low - Here's What Happened
03 Mar 2025 13:16:14 By Buzz FX
-
NIOX Group (LON:NIOX) Hits New 12-Month Low - Here's Why
03 Mar 2025 13:16:14 By Buzz FX
-
MNI BRIEF: Fed's Musalem Calls For Patient Approach To Policy
03 Mar 2025 13:12:22 By Buzz FX
-
Musalem Says Inflation Expectations Key If Fed's Goals Conflict
03 Mar 2025 13:11:23 By Buzz FX
-
GOP lawmakers urge Trump to pick regulatory chair at Fed
03 Mar 2025 13:11:23 By Buzz FX
-
China's February manufacturing hits 3-month high
03 Mar 2025 13:11:23 By Buzz FX
-
India's economic growth picks up on rising govt, consumer spending
03 Mar 2025 13:10:21 By Buzz FX
-
'Capt Crypto' Trump targets Fed freedom
03 Mar 2025 13:00:23 By Buzz FX
-
Australian dollar ends skid, retail sales and RBA minutes next
03 Mar 2025 12:56:13 By Buzz FX
-
Needham & Company LLC Cuts International Money Express (NASDAQ:IMXI) Price Target to $20.00
03 Mar 2025 12:56:13 By Buzz FX
-
MasTec (NYSE:MTZ) Given New $175.00 Price Target at Stifel Nicolaus
03 Mar 2025 12:56:13 By Buzz FX
-
Lexicon Pharmaceuticals (NASDAQ:LXRX) Earns "Buy" Rating from HC Wainwright
03 Mar 2025 12:56:13 By Buzz FX
-
Axsome Therapeutics (NASDAQ:AXSM) Given "Buy" Rating at Needham & Company LLC
03 Mar 2025 12:56:13 By Buzz FX
-
Integral Ad Science (NASDAQ:IAS) Stock Price Expected to Rise, Morgan Stanley Analyst Says
03 Mar 2025 12:56:13 By Buzz FX
-
Rocket Companies (NYSE:RKT) Given New $12.00 Price Target at Keefe, Bruyette & Woods
03 Mar 2025 12:56:13 By Buzz FX
-
Needham & Company LLC Reaffirms "Hold" Rating for Lexicon Pharmaceuticals (NASDAQ:LXRX)
03 Mar 2025 12:56:13 By Buzz FX
-
Arhaus (NASDAQ:ARHS) Price Target Lowered to $11.50 at Stifel Nicolaus
03 Mar 2025 12:56:13 By Buzz FX
-
Morgan Stanley Lowers EOG Resources (NYSE:EOG) Price Target to $142.00
03 Mar 2025 12:56:13 By Buzz FX
-
Protagonist Therapeutics' (PTGX) Buy Rating Reaffirmed at HC Wainwright
03 Mar 2025 12:56:13 By Buzz FX